Alemtuzumab

Results: 47



#Item
11PRESS RELEASE At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies - In approximately 70 percent of patients, disability scores improved or

PRESS RELEASE At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies - In approximately 70 percent of patients, disability scores improved or

Add to Reading List

Source URL: en.sanofi.com

Language: English - Date: 2014-10-09 14:57:39
12HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA. LEMTRADA™ (alemtuzumab) injection,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA. LEMTRADA™ (alemtuzumab) injection,

Add to Reading List

Source URL: products.sanofi.us

Language: English - Date: 2014-12-11 14:21:32
13Effacer Imprimer DEMANDE D’AUTORISATION DE PAIEMENT Alemtuzumab (LemtradaMC) — Sclérose en plaques de formes rémittente

Effacer Imprimer DEMANDE D’AUTORISATION DE PAIEMENT Alemtuzumab (LemtradaMC) — Sclérose en plaques de formes rémittente

Add to Reading List

Source URL: www.ramq.gouv.qc.ca

Language: French - Date: 2014-11-13 13:32:18
    14ISF35 Active Immunotherapy for Blood Cancer NIH Protocol #[removed]Phase Ib Study of Autologous Ad-­‐ISF35-­‐Transduced CLL B Cells and Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Subjects with Fludarabin

    ISF35 Active Immunotherapy for Blood Cancer NIH Protocol #[removed]Phase Ib Study of Autologous Ad-­‐ISF35-­‐Transduced CLL B Cells and Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Subjects with Fludarabin

    Add to Reading List

    Source URL: osp.od.nih.gov

    Language: English - Date: 2013-12-31 14:02:52
    15I DEPARTMENT OF HEALTH &aHUMAN SERWCES Food and Drug Administration

    I DEPARTMENT OF HEALTH &aHUMAN SERWCES Food and Drug Administration

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    16Millennium and ILEX Partners, LP Campath® (Alemtuzumab) 1 Page 1 of 14

    Millennium and ILEX Partners, LP Campath® (Alemtuzumab) 1 Page 1 of 14

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    17FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) Meeting Sheraton Silver Spring Hotel, Cypress Ballroom 8777 Georgia

    FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) Meeting Sheraton Silver Spring Hotel, Cypress Ballroom 8777 Georgia

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    18Kidney transplant drug halves the early risk of rejection and allows less toxic treatment

    Kidney transplant drug halves the early risk of rejection and allows less toxic treatment

    Add to Reading List

    Source URL: medicalxpress.com

    Language: English - Date: 2014-10-29 00:21:45
    19PRESS RELEASE Slowing of Brain Atrophy and Reductions in New Multiple Sclerosis Lesions Sustained at Three Years in Patients Treated with Genzyme’s LemtradaTM - Consistent effects seen across key MRI measures of disea

    PRESS RELEASE Slowing of Brain Atrophy and Reductions in New Multiple Sclerosis Lesions Sustained at Three Years in Patients Treated with Genzyme’s LemtradaTM - Consistent effects seen across key MRI measures of disea

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-10-09 14:55:47
    20Microsoft Word - CLL Working Group - Meeting Summary[removed]docx

    Microsoft Word - CLL Working Group - Meeting Summary[removed]docx

    Add to Reading List

    Source URL: www.cancer.gov

    Language: English - Date: 2014-06-30 21:59:30